ERBB2 and pancreatic adenocarcinoma: ERBB2 gene enrichment has an increasing trend in pathological stages I–IV of PAAD and UCEC, while their performance appears to have a decreasing tendency in pathological stages I–IV of KICH and KIRC (Figure 1E).